VYOME HOLDINGS, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
VYOME HOLDINGS, INC. (HIND) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $11.05 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-12
- VYOME HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $11.05K, a 7.91% decline year-over-year.
- VYOME HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $5.70K, a 62.03% decline year-over-year.
- VYOME HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was -$23.98K, a 259.87% decline year-over-year.
- VYOME HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $574.11K, a 1694.09% increase year-over-year.
- VYOME HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $577.13K, a 213.66% increase from fiscal 2024.
- VYOME HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $184.00K, a 75.98% decline from fiscal 2023.
- VYOME HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $766.00K, a 63.30% decline from fiscal 2022.
- VYOME HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $2.09M, a 82.93% decline from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $11.05K 10-Q · filed 2026-08-12 | $16.75K derived: sum of 2 quarters · filed 2026-08-12 | -$7.23K derived: sum of 3 quarters · filed 2026-08-12 | $566.88K derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | $5.70K 10-Q · filed 2026-08-12 | -$18.29K derived: sum of 2 quarters · filed 2026-08-12 | $555.82K derived: sum of 3 quarters · filed 2026-08-12 | $567.82K derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | -$23.98K derived: 10-K 12 month − 3 quarters · filed 2026-03-18 | $550.13K derived: sum of 2 quarters · filed 2026-03-18 | $562.13K derived: sum of 3 quarters · filed 2026-03-18 | $577.13K 10-K · filed 2026-03-18 | ||||
| 2025-09-30 | $574.11K 10-Q · filed 2025-11-14 | $586.11K derived: sum of 2 quarters · filed 2025-11-14 | $601.11K derived: sum of 3 quarters · filed 2025-11-14 | $616.11K derived: sum of 4 quarters · filed 2025-11-14 | ||||
| 2025-06-30 | $12.00K 10-Q · filed 2025-08-14 | $27.00K 10-Q · filed 2025-08-14 | $42.00K derived: sum of 3 quarters · filed 2025-08-14 | $74.00K derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2025-03-31 | $15.00K 10-Q · filed 2025-05-20 | $30.00K derived: sum of 2 quarters · filed 2025-05-20 | $62.00K derived: sum of 3 quarters · filed 2025-05-20 | $127.00K derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | $47.00K derived: sum of 2 quarters · filed 2025-04-04 | $112.00K derived: sum of 3 quarters · filed 2025-08-14 | $184.00K 10-K · filed 2025-04-04 | ||||
| 2024-09-30 | $32.00K 10-Q · filed 2024-11-14 | $97.00K derived: sum of 2 quarters · filed 2025-08-14 | $169.00K 10-Q · filed 2024-11-14 | $279.00K derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-06-30 | $65.00K 10-Q · filed 2025-08-14 | $137.00K 10-Q · filed 2025-08-14 | $247.00K derived: sum of 3 quarters · filed 2025-08-14 | $463.00K derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $72.00K 10-Q · filed 2025-05-20 | $182.00K derived: sum of 2 quarters · filed 2025-05-20 | $398.00K derived: sum of 3 quarters · filed 2025-05-20 | $615.00K derived: sum of 4 quarters · filed 2025-05-20 | ||||
| 2023-12-31 | $110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | $326.00K derived: sum of 2 quarters · filed 2025-04-04 | $543.00K derived: sum of 3 quarters · filed 2025-04-04 | $766.00K 10-K · filed 2025-04-04 | ||||
| 2023-09-30 | $216.00K 10-Q · filed 2024-11-14 | $433.00K derived: sum of 2 quarters · filed 2024-11-14 | $656.00K 10-Q · filed 2024-11-14 | $894.00K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $217.00K 10-Q · filed 2024-08-14 | $440.00K 10-Q · filed 2024-08-14 | $678.00K derived: sum of 3 quarters · filed 2024-08-14 | $1.04M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $222.00K 10-Q · filed 2024-05-15 | $461.00K derived: sum of 2 quarters · filed 2024-05-15 | $820.00K derived: sum of 3 quarters · filed 2024-05-15 | $1.59M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $239.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $598.00K derived: sum of 2 quarters · filed 2024-04-01 | $1.37M derived: sum of 3 quarters · filed 2024-04-01 | $2.09M 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $359.00K 10-Q · filed 2023-11-09 | $388.00K 10-Q · filed 2022-11-14 | $1.13M derived: sum of 2 quarters · filed 2023-11-09 | $1.85M 10-Q · filed 2023-11-09 | $1.96M 10-Q · filed 2022-11-14 | $4.10M derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | $770.00K 10-Q · filed 2023-08-07 | $823.00K 10-Q · filed 2022-08-19 | $1.49M 10-Q · filed 2023-08-07 | $1.57M 10-Q · filed 2022-08-19 | $3.75M derived: sum of 3 quarters · filed 2023-08-07 | $13.98M derived: sum of 4 quarters · filed 2023-08-07 | ||
| 2022-03-31 | $719.00K 10-Q · filed 2023-05-15 | $747.00K 10-Q · filed 2022-05-23 | $2.98M derived: sum of 2 quarters · filed 2023-05-15 | $13.21M derived: sum of 3 quarters · filed 2023-05-15 | $12.85M derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | $2.26M derived: 10-K 12 month − 10-K 9 month · filed 2023-04-17 | $12.49M derived: sum of 2 quarters · filed 2023-04-17 | $12.13M derived: sum of 3 quarters · filed 2023-04-17 | $12.23M 10-K · filed 2023-04-17 | $12.75M 10-K · filed 2022-04-08 | |||
| 2021-09-30 | $10.23M 10-K · filed 2023-04-17 | $10.72M 10-Q · filed 2021-11-12 | $9.87M derived: sum of 2 quarters · filed 2023-04-17 | $9.97M 10-K · filed 2023-04-17 | $10.46M 10-Q · filed 2021-11-12 | $10.27M derived: sum of 4 quarters · filed 2023-04-17 | ||
| 2021-06-30 | -$364.00K 10-Q · filed 2022-08-19 | -$263.00K 10-Q · filed 2022-08-19 | $31.00K derived: sum of 3 quarters · filed 2022-08-19 | $286.00K derived: sum of 4 quarters · filed 2022-08-19 | ||||
| 2021-03-31 | $101.00K 10-Q · filed 2022-05-23 | $91.00K 10-Q · filed 2021-05-12 | $395.00K derived: sum of 2 quarters · filed 2022-05-23 | $650.00K derived: sum of 3 quarters · filed 2022-05-23 | $997.00K derived: sum of 4 quarters · filed 2022-05-23 | |||
| 2020-12-31 | $294.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $549.00K derived: sum of 2 quarters · filed 2022-04-08 | $896.00K derived: sum of 3 quarters · filed 2022-04-08 | $1.32M 10-K · filed 2022-04-08 | $1.09M 10-K · filed 2021-03-12 | |||
| 2020-09-30 | $255.00K 10-Q · filed 2021-11-12 | $259.00K 10-Q · filed 2020-11-06 | $602.00K derived: sum of 2 quarters · filed 2021-11-12 | $1.03M 10-Q · filed 2021-11-12 | ||||
| 2020-06-30 | $347.00K 10-Q · filed 2021-08-16 | $292.00K 10-Q · filed 2020-07-30 | $774.00K 10-Q · filed 2021-08-16 | |||||
| 2020-03-31 | $470.00K 10-Q · filed 2021-05-12 | |||||||
| 2019-12-31 | $2.98M 10-K · filed 2021-03-12 | |||||||
| 2019-09-30 | $659.00K 10-Q · filed 2020-11-06 | $1.20M derived: sum of 2 quarters · filed 2020-11-06 | $2.30M derived: sum of 3 quarters · filed 2020-11-06 | |||||
| 2019-06-30 | $536.00K 10-Q · filed 2020-11-06 | $1.64M derived: sum of 2 quarters · filed 2020-11-06 | ||||||
| 2019-03-31 | $1.10M 10-Q · filed 2020-11-06 | |||||||
| 2018-12-31 | $4.69M 10-K · filed 2020-02-27 | |||||||
| 2018-09-30 | $1.01M 10-Q · filed 2019-11-08 | $2.22M derived: sum of 2 quarters · filed 2019-11-08 | $3.61M derived: sum of 3 quarters · filed 2019-11-08 | |||||
| 2018-06-30 | $1.21M 10-Q · filed 2019-11-08 | $2.60M derived: sum of 2 quarters · filed 2019-11-08 | ||||||
| 2018-03-31 | $1.39M 10-Q · filed 2019-11-08 | |||||||
| 2017-12-31 | $3.24M 10-K · filed 2019-02-22 | |||||||
| 2016-12-31 | $563.00K 10-K · filed 2018-03-05 | |||||||
| 2015-12-31 | $207.00K 10-K · filed 2018-03-05 | |||||||
| 2014-12-31 | $185.00K 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |